CVRS News

Corindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, raised $42 million on Thursday night by offering 11 million shares at $3.80. The company's stock had been trading on the OTCQB under the symbol CVRS at $4.25 when Corindus set terms on Tuesday for the public offering. Its shares had fallen to $4.00 on Friday on...read more

Corindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, announced terms for its IPO on Tuesday. The Waltham, MA-based company plans to offer 11 million shares. Assuming the company prices at $4.25 (its last closing price on the OTC), Corindus Vascular Robotics would raise $47 million and command a fully diluted market value of...read more

Corindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, filed on Monday with the SEC to raise up to $40 million in a US public offering. The stock currently trades on the OTCQB under the symbol CVRS and has a market cap of about $450 million. The Waltham, MA-based company, which was founded in 2011 and booked $3 million in...read more